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Uptake and acceptability of antenatal HIV testing:
randomised controlled trial of different methods of
offering the test
Wendy M Simpson, Frank D Johnstone, Fiona M Boyd, David J Goldberg, Graham J Hart,
Robin J Prescott
Abstract
Objective: To determine the uptake and acceptability
of different methods of a universal offer of voluntary
HIV testing to pregnant women.
Design: Randomised controlled trial involving four
combinations of written and verbal communication,
followed by the direct offer of a test. The control
group received no information and no direct offer of
a test, although testing was available on request.
Setting: Hospital antenatal clinic covering most of the
population of the city of Edinburgh.
Subjects: 3024 pregnant women booking at the clinic
over a 10 month period.
Main outcome measures: Uptake of HIV testing and
women’s knowledge, satisfaction, and anxiety.
Results: Uptake rates were 6% for those in the control
group and 35% for those directly offered the test.
Neither the style of leaflet nor the length of discussion
had an effect on uptake. Significant independent
predictors of uptake were a direct test offer; the
midwife seen; and being unmarried, previously tested,
and younger age. Knowledge of the specific benefits of
testing increased with the amount of information
given, but neither satisfaction nor anxiety was affected
by the type of offer.
Conclusions: The universal offer of HIV testing is not
intrusive and is acceptable to pregnant women. A
policy of offering the HIV test to all women resulted
in higher uptake and did not increase anxiety or
dissatisfaction. Uptake depends more on the midwife
than the method of offering the test. Low uptake rates
and inadequate detection of HIV infection point to
the need to assess a more routine approach to testing.
Introduction
With increasing optimism about the benefits of
antenatal HIV testing in terms of measures that can
greatly reduce the chance of the baby being infected,1 3
there is a demand for effective, acceptable programmes
of testing and appropriate patient information.4 This
study was designed to respond to this demand by com›
paring different ways of offering voluntary testing to all
pregnant women in a randomised, controlled trial.
Currently, antenatal testing policies, practices, and
uptake rates vary,5–8 and this has encouraged debate
about how testing should be offered: to all women
(universal policy), selectively (for those with recognised
risk factors), or on a “request only” basis. Another con›
flict of opinion has been whether the test should be
offered with comprehensive information, as would be
done in an HIV testing clinic, or whether it should be
offered more in line with the other antenatal blood
tests, with minimal information. Minimal information
may be more likely to achieve high uptake.7–9 Compre›
hensive information aims to ensure informed choice
but may result in high costs in midwives’ time and
increased anxiety.10 Studies have examined the
outcomes of the different policies,4–11 but the different
methods have not been compared systematically, with
an evaluation of the direct impact on women.
Although most women are at low risk, the offer of the
test may itself cause anxiety, as has been found with
other antenatal tests,12 and feelings of resentment
about being offered the test may reduce satisfaction
with the care provided.
The prevalence of HIV infection in Edinburgh
(1:660 deliveries 1990›5) has fallen since its peak of
1:250 deliveries in 1986 but remains high in compari›
son to many centres.13 Before this trial, there was no
universal testing policy in Edinburgh and only a small
percentage of women attending antenatal clinics were
selectively offered the test, most commonly because of
a history of intravenous drug use. In the years immedi›
ately preceding the study, less than 1% of women seen
antenatally had an HIV test during pregnancy. Because
of this relatively high prevalence and the lack of a uni›
versal testing policy, Edinburgh was ideally suited for
this randomised controlled trial.
The study aimed to determine whether different
methods of offering the test would lead to significantly
different uptake rates and to assess the impact of the
different methods on the woman’s response in terms of
her satisfaction, anxiety, and knowledge. Demographic
and situational factors were examined to determine
their effect on uptake. The goal was to have sufficient
information to define the most effective and acceptable
approach to testing. The methodology was approved
by Lothian Reproductive Medicine Ethics Committee.
Methods
Design, setting, and subjects
The study was a randomised controlled trial in the
main maternity hospital in the city of Edinburgh
(about 5000 deliveries a year). The randomly allocated
interventions (table 1) were different presentations of
an offer of voluntary named HIV testing to all
pregnant women attending the antenatal clinic for
their first (booking) visit to the hospital during a 10
month period from May 1996 to February 1997.
Women in the four intervention groups were
directly offered the test by a midwife (universal policy).
Women in the control group were not routinely
offered a test and were not, individually, given any
information about the test, either verbally or in print,
unless they asked. This was the clinical situation before
the study.14 However, testing was advertised by poster,
and the information letter about the study made it
clear to women in this group that the test was available
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and that they could ask for a test if they wanted it
(request policy). This was done because we believed
that current acceptable practice had to include easy
availability of HIV testing.
Key outcomes were uptake of testing and women’s
knowledge of HIV, satisfaction with consultation, and
anxiety.
Procedure
All women for whom a postal booking appointment
was made during the 10 months of the study were ran›
domised. In response to referral from the general
practitioner, each patient was assigned an antenatal
number generated by the hospital computer. This
marked the point of formal entry to the trial, and each
woman was randomly assigned by a computer
programme to one of five groups. Within blocks of 24
successive women, eight were allocated to the control
group and four to each of the intervention groups.
An information letter was sent to all women with
the booking information package, explaining the
nature and purpose of the study. It explained that she
could choose whether or not she wanted an HIV test
and that the questionnaire was voluntary. An
information leaflet, if applicable, was enclosed within
the posted information. Later, at the booking clinic,
each woman was approached by the research midwife
and was given the opportunity to opt out of participat›
ing in the study. A coded sticker inside the patient’s
notes showed the midwives which discussion protocol
to use during the consultation. Women were excluded
if they were known to be HIV positive and if there was
language difficulty and no interpreter was available, but
this information was available only after randomisation
and after the study information had been sent, so
exclusions were made at time of booking: in these cases
the midwife did not discuss HIV testing.
Most bookings were carried out by 10 midwives
who all received training in offering the test by using
the two discussion protocols designed for the study.
The training involved role play and information
sharing between the midwives, the research team, and a
specialist HIV counsellor. The two protocols were
introduced and the importance of the distinction
between them was emphasised. Throughout the study,
occasional meetings provided support and continued
emphasis on the distinction between the two protocols.
A researcher also periodically monitored all midwives’
consultations to ensure that the protocols were being
followed.
If the woman decided to take the test, she was
required to sign a consent form. In this event, the blood
sample which was used to test for syphilis was also
tested for HIV.
Immediately after the consultation with the
midwife, women were asked to complete the question›
naire, which assessed their knowledge, satisfaction, and
anxiety.
To determine HIV prevalence among childbearing
women in Scotland, unlinked anonymous HIV testing
of dried blood spots from Guthrie cards obtained from
neonates has been performed since Jnuary 1990.
Guthrie cards corresponding to all pregnant women
included in the study were coded to establish if the
women had belonged to either the control or the inter›
vention group. This enabled the investigators to deter›
mine how many women in the study population who
did not have an HIV test were antibody positive
Materials
Leaflets—Two types of leaflet were developed with
professional help and piloted with pregnant women.
The “HIV specific” leaflet (Flesch score 65, indicating
good readability15) explained in some detail the
benefits of offering testing, with particular reference to
treatment with zidovudine (AZT) and avoidance of
breast feeding. It also explained what the test is and
what the results mean; stated the disadvantages of test›
ing; and gave information about insurance and about
HIV transmission. It explained that the midwife would
offer the test and what it would involve and it
emphasised that testing was the woman’s choice. The
“blood tests” leaflet (Flesch score 66) contained a short
summary of the “HIV specific” leaflet as part of
information about all the blood tests that were
available, with the aim of normalising HIV testing. This
leaflet noted that testing could benefit the baby but did
not provide specific details.
Pretest discussion protocols—The two discussion
protocols were printed on card and were placed in
each consulting room for the midwives’ reference. The
“comprehensive” protocol (two pages of A4 paper),
developed with professional help and with reference to
guidelines,16 17covered the main information points
included in the “HIV specific” leaflet, re›emphasising
the benefits of testing for the baby. Personal risk, the
possibility of a positive result, and the support available
were also discussed if a woman decided to take the test.
The “minimal” protocol (half a page of A4 paper) was
a short check that the woman had read and
understood the leaflet and that she knew what both a
positive and negative result implied. If she decided to
take the test she was given information about what the
test involved.
Questionnaire—The questionnaire contained a
standardised scale to measure anxiety (six item form of
the Spielberger state trait anxiety inventory18) and spe›
cific questions and scales developed for this particular
study, based on measures reported in various previous
papers. Internal consistencies of the main outcome
scales were high: knowledge of HIV (11 items,
Cronbach’s á = 0.91); satisfaction (5 items, Cronbach’s
á = 0.91); and anxiety (6 items, Cronbach’s á = 0.89).
Midwives’ checklist—The midwives noted uptake,
which was checked with the laboratory reports. They
also noted time taken for discussing HIV, any previous
HIV testing, whether the woman or her partner was an
intravenous drug user, and nationality.
Table 1 Characteristics of study groups
Group Leaflet
Discussion with
midwife
Offered
testing
No (%) completing
questionnaire*
1 None None No† 882/994 (89)
2 All blood tests Minimal Yes 441/495 (89)
3 All blood tests Comprehensive Yes 478/521 (92)
4 HIV specific Minimal Yes 453/495 (92)
5 HIV specific Comprehensive Yes 450/519 (87)
*Denominators represent women who were randomised and participated in the trial; all were included in the
primary end point (uptake rate).
†HIV testing was available on request for this group and was advertised in a letter about the study sent to
all women and by poster in the clinic.
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Demographic variables—Demographic variables were
collected by the midwife at the time of the booking visit
and were later downloaded from the hospital computer.
The known HIV prevalence in the area of Edinburgh in
which the women lived was used as an indirect measure
of risk: a five point “area risk” code (1 = no HIV cases in
area; 5 = > 1 case per 1000) was derived on the basis of
the number of people identified as being infected with
HIV who were alive in each postcode area to the end of
1996 (excluding homosexual and bisexual men).19 A
seven point social deprivation score was also derived
from postcodes (1 = highly affluent; 7 = very deprived).20
As data from the hospital computer were incomplete,
data for the demographic variables were missing for
some women.
Statistical methods
The target sample size of 3000 was chosen to have
approximately 90% power to show a significant change
(P < 0.05) in uptake from 70% to 80% between
intervention groups.
Statistical analysis was done using spss; all analyses
were by intention to treat. Proportions of women
taking the test were compared with the ÷2 test, using the
Mantel›Haenszel trend test for ordinal variables.
Logistic regression methods were used to determine
the significant independent predictors of uptake.
Knowledge was analysed with the ÷2 test, comparing
the proportion who made the correct response with
those who made an incorrect or “don’t know” response
for each item separately. A satisfaction score was
devised as the sum of all five items and was compared
across groups by using non›parametric analysis of
variance (Kruskal›Wallis) because of the positively
skewed distribution. The anxiety score (sum of all six
items, pro›rated to be comparable to the original 20
item scale) was compared across groups by using one
way analyses of variance.
Results
Sample
In all, 3505 pregnant women were randomised over
the 10 month period; 3024 women participated. One
woman was excluded because she was known to be
HIV positive and six because of language difficulty (two
were Pakistani, two Chinese, one Russian, and one Ital›
ian). A total of 311 women did not participate because
of miscarriages or terminations before booking; 33 did
not receive information about the study through the
post; 119 never attended the clinic; and 11 refused to
participate. Characteristics in the five study groups did
not differ (table 2).
Thirty five women were defined as high risk
because either they or their partner were intravenous
drug users. These women were all randomised into the
study, but they were treated as they would have been
before the study began. Regardless of intervention
group, there was a policy of selective testing for all
women at high risk.
Uptake
Table 3 shows uptake rates for each of the five study
groups. The average uptake for all women offered the
test (excluding the control group) was 35%. Each of the
methods of directly offering the test resulted in a
higher uptake than in the control group (6% uptake)
(÷2 = 308.5, df = 4, P < 0.0001). However, there was no
significant difference between the four methods of
directly offering the test (÷2 = 3.9, df = 3, P = 0.27).
Of the 760 women tested, one woman was newly
identified as HIV positive. One woman previously
known to be HIV positive was included in the sample.
Three HIV infected women were not detected during
Table 2 Characteristics of women in intervention groups
Characteristic
Group
Significance1 2 3 4 5
Mean (SD) age (years) 29.3 (5.4) 29.4 (5.3) 29.8 (5.5) 29.6 (5.5) 29.6 (5.5) F(4,3009)=0.89, P=0.47
No (%) married 661/974 (67.9) 357/487 (73.3) 372/512 (72.6) 355/491 (72.3) 350/504 (69.4) ÷2=7.3, df=4, P=0.12
No (%) primiparous 516/990 (52.1) 236/492 (48.0) 232/518 (44.8) 241/494 (48.8) 249/516 (48.2) ÷2=7.9, df=4, P=0.10
No (%) unemployed 64/835 (7.7) 29/409 (7.1) 29/448 (6.5) 26/422 (6.2) 31/432 (7.2) ÷2=1.2, df=4, P=0.87
Area risk code (No (%) at lower risk)* 404/966 (41.8) 190/477 (39.8) 213/506 (42.1) 199/475 (41.9) 211/498 (42.4) ÷2=0.8, df=4, P=0.94
Social deprivation score (% affluent)† 481/848 (56.7) 227/419 (54.2) 231/448 (51.6) 224/409 (54.8) 238/436 (54.6) ÷2=3.2, df=4, P=0.52
*Split into two groups: lower risk group includes groups 1 and 2 of the five categories.
†Split into two groups: affluent group contains groups 1, 2, and 3 of the seven categories.
Table 3 Effect of intervention on uptake of HIV testing
Group
Significance1 2 3 4 5
No (%) tested 55/994
(5.5)
179/495
(36.2)
193/521
(37.0)
171/495
(34.5)
164/519
(31.6)
÷2=308.5,
P<0.001
Table 4 The effect of demographic factors and previous testing on uptake of HIV
testing. Values are numbers (percentages) of women taking test
Variable No (%) taking test ÷2 P value
Age:
Older (>30 years) 367/1579 (23.2)
6.97 P<0.01
Younger (<30 years) 393/1433 (27.4)
Marital status:
Married 468/2095 (22.3)
28.9 P<0.001
Single 277/873 (31.7)
Parity:
Multiparous 377/1536 (24.5)
0.75 P>0.05
Primiparous 382/1474 (25.9)
Employed in or outside the home:
Yes 574/2367 (24.2)
15.3 P<0.001
No 67/179 (37.4)
Previous test:
Yes 131/298 (43.9)
49.4 P<0.001
No 596/2402 (24.8)
Table 5 Effect of risk of HIV (derived from postcode area) on uptake of HIV testing
by women attending antenatal clinics
Area 1 2 3 4 5 Significance
No (%)
taking test
48/173
(28)
158/692
(23)
87/352
(25)
261/954
(27)
184/751
(25)
Mantel›Haenszel
÷2=0.32, P>0.05
Group 1 has no HIV cases; group 5 has >1 case per 1000 population.
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the 10 month trial; two of the three had been
randomised to the control group.
What predicts uptake?
Tables 4›8 show that the best independent predictor of
uptake was being directly offered the test, followed, in
order, by which midwife offered the test, not being
married, having had a previous test, and being
younger. Although deprivation score (table 6) and
employment status (table 4) were related to uptake,
they were not significant independent predictors.
Acceptability of testing
Overall, 89% (2703/3024) responded to the question›
naire (table 1), and 88% of women (2362/2699)
responded positively to the question, “Are you in
favour of an HIV test being available to all pregnant
women?” When they were asked to choose the best of
five methods of offering the test, only 210 (9%)
reported that it should be left up to the woman to
request the test from the midwife.
Knowledge of HIV
General knowledge of HIV was good and did not differ
significantly by method of offering testing (data not
shown). Specific knowledge about vertical transmission
and the effects of zidovudine and breast feeding, which
was provided only in the “HIV specific” leaflet and the
comprehensive discussion protocol, was much poorer.
Intervention had a significant effect on specific HIV
knowledge (table 9). Knowledge was greatest when the
information was repeated in both the leaflet and the
discussion (group 5).
Satisfaction
In general, satisfaction with the consultation was high
(mean (SD) score 21.5 (3.4), maximum possible = 25).
Satisfaction was not affected by the method of offering
testing (Kruskal›Wallis ÷2 = 2.23, df = 4, P = 0.69) (data
not shown).
Anxiety
The anxiety level of the entire sample (pro›rated mean
36.7 (11.0), maximum possible = 80) was similar to that
found previously in a group of 200 pregnant women
and lower than in women who had received an á feto›
protein screening result showing the fetus was at high
risk (47.7 (15.8), maximum = 80).18 Anxiety was not
affected by method of offering testing (F(4, 2568) = 1.38,
P = 0.24) (data not shown).
Time taken for discussion
The average time taken for the comprehensive
protocol was 7 minutes 40 seconds (SD = 4 minutes 30
seconds) and for the minimal protocol, 4 minutes 30
seconds (3 minutes 5 seconds).
Table 6 Effect of social deprivation on uptake of HIV testing by women attending antenatal clinics
Social deprivation
score 1 2 3 4 5 6 7 Significance
No (%) of women
taking test
108/490 (22) 112/509 (22) 98/402 (24) 208/828 (25) 33/144 (23) 28/94 (30) 33/93 (35) Mantel›Haenszel
÷2=7.8, P<0.01
Derived from postcode area; 1=highly affluent; 7=very deprived.20
Table 7 Effect of midwife on uptake of HIV testing by women attending antenatal clinics
Midwife A B C D* E F G H I J K Significance
No (%) of women
taking test
52/353
(15)
21/134
(16)
55/316
(17)
63/291
(22)
68/312
(22)
41/170
(24)
138/492
(28)
78/263
(30)
61/188
(32)
119/361
(33)
66/138
(48)
÷2=100.2, P<0.001
*The 10 midwives in this group were not analysed individually as they each did <63 bookings; each of the other 10 midwives did >130 bookings.
Table 8 Significant predictors of uptake of HIV testing found with logistic regression analyses (forward conditional method)
Factor
Measures
Wald ÷2 df P value Odds ratio (95% CI)
Offer of testing (offered testing directly v being in the control group) 186.8 1 <0.0001 8.4 (6.2 to 11.5)
Midwife* 84.3 10 <0.0001 —
Marital status (married v being single) 20.9 1 <0.0001 0.59 (0.46 to 0.74)
Previous test (yes v no) 11.5 1 0.0007 1.6 (1.2 to 2.1)
Age (increase in age, fitted as continuous variable) 6.6 1 0.01 0.98 (0.96 to 0.99)
*Single odds ratio cannot be calculated for overall effect of all midwives.
Table 9 Specific knowledge about HIV by method of offering the test
Group Leaflet Discussion with midwife
No (%) giving correct answer
Breast feeding* Zidovudine†
1 None None 263/865 (30) 128/865 (15)
2 All blood tests Minimal 128/435 (29) 87/438 (20)
3 All blood tests Comprehensive 284/468 (61) 190/470 (40)
4 HIV specific Minimal 202/448 (45) 171/448 (38)
5 HIV specific Comprehensive 309/446 (69) 243/446 (54)
Significance ÷2= 267.4, df=4, P<0.001 ÷2= 277.8, df=4, P<0.001
*“A pregnant woman who has HIV can infect her baby through breast feeding.”
†“A pregnant woman who has HIV can reduce the chance of her baby becoming infected by taking zidovudine (AZT).”
Papers
265BMJ VOLUME 316 24 JANUARY 1998
Discussion
The antenatal booking visit is a sensitive time: much
information is being exchanged, and it is important
that the introduction of a new screening test will not
adversely affect the experience. This, added to the con›
troversy surrounding HIV testing, has led to particular
concern among health professionals about the
introduction of HIV testing into antenatal care. Our
data show that this apprehension is unfounded.
Women were willing to discuss their attitudes to HIV
testing and were positive about the availability of
testing. Moreover, the universal offer of testing did
not seem to be intrusive to the booking visit or to
cause anxiety, and it was not inappropriately time
consuming.
Methodological considerations
The control group was necessary for methodological
reasons, but raised important ethical issues. For the
study to be acceptable to the ethical committee and to
the patient representative groups we contacted, we had
to make it clear to the control group that the trial was
taking place and that they could ask for an HIV test. In
response to this, there was an increase in testing from
less than 1% in the previous year to 6%, and thus more
women in this group had testing than would otherwise
have been the case.
Although uptake was much lower than expected for
the sample size calculation, the power to detect a differ›
ence of 10% between groups is unchanged. The
expected uptake rate was based on the findings of a
study in Edinburgh that found an uptake rate of 71%.21
This large difference in uptake rate between the two
studies is perhaps a reflection of the way the test was
presented. While the previous study emphasised the
research purpose of determining HIV prevalence, the
present study was geared towards women’s choice rather
than deliberately aiming to increase testing rates.
Types of offer
Offering the test to all women compared to “on
request” availability (as in the control group) resulted
in significantly higher uptake but did not increase the
women’s anxiety or dissatisfaction. No one method of
offering the test emerged as the most acceptable.
Neither anxiety nor dissatisfaction increased with the
amount of information given, lending no support to
previous suggestions that comprehensive discussion
may have an adverse impact.10 Nor did one method of
offering the test emerge as the most effective, as shown
by uptake, suggesting that the extent of information
given is irrelevant. Previous research on prenatal
testing for cystic fibrosis has shown that more
information results in lower uptake,9 but this is not
supported by our findings.
However, knowledge of specific benefits of testing
increased with the amount of information given. This
is an important indication that the midwives followed
the discussion protocols and that the interventions
were systematically different. It also shows that provid›
ing specific information can increase women’s
informed choice, which is a desirable outcome. So,
although prolonged discussion along the lines of the
HIV testing clinic model is not necessary, specific ben›
efits should be highlighted.
Factors affecting uptake
Being unmarried and younger were independent
demographic predictors suggesting that women were
making the decision to take the test on the basis of per›
sonal risk assessment. The univariate finding that
uptake increased with extent of social deprivation sup›
ports this assertion. However, there was no effect of risk
area on uptake, suggesting that women at higher risk in
terms of possible local exposure to the virus were no
more likely to take the test than women at very low risk.
The midwife had a very important effect on uptake.
This supports the findings of a smaller study (n = 448)
which recorded much wider differences between 12
midwives (3%›82%).22 In this study we found that even
though we provided the midwives with the same infor›
mation during training and gave them clear, written
protocols to work from, their uptake rates were signifi›
cantly different. This challenges the prevalent assump›
tion that the behaviour of health professionals is based
solely on the extent of their medical knowledge.
Marteau and Johnston have argued that psychological
models used to predict patients’ behaviour should also
be applied to health professionals, implying that
midwives’ attitudes should be taken into account when
considering uptake of testing.23
Benefits of routine offer
Our study focused on women’s choice and assessed
opinion, satisfaction, and anxiety. Nevertheless the
main point of offering HIV testing is to enable infected
women to take steps to prevent vertical transmission.
The prevalence of HIV infection shown by ano›
nymised testing was similar to that in previous years
(1 in 600 deliveries). What was unexpected and quite
out of keeping with past experience13 was the high
proportion of infected women in whom seropositivity
was unknown. During the study, one HIV positive
woman was detected out of two who were offered the
test. Two unknown positive women in the control
group did not request testing, which reinforces the
necessity for the test to be offered to pregnant women
rather than simply be available on request. Whether
Recommendations
• In areas where unlinked anonymous HIV testing
indicates appreciable levels of undetected HIV
infection in childbearing women, all women attending
antenatal clinics should be offered the test and
midwives should be required to keep a record of the
offer
• Leaflets specifically about HIV infection and about
all blood tests both have advantages. We recommend a
leaflet containing information about all blood tests, but
including more information about HIV, specifying
clearly the benefits of testing during pregnancy
• A minimal approach to discussion is advised as it
will cost less in terms of midwives’ time, but it should
contain specific information on the benefits of testing
• Midwives play an important role in affecting uptake,
and research should focus on differences between
midwives that may affect uptake rates
• In an attempt to increase uptake and detection rates,
a routine approach to testing should be assessed
systematically
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another voluntary sytem would be more effective is not
certain. Out of 35 women selectively offered testing
because of a history of injecting drug use (self or part›
ner), 14 declined HIV testing.
In London, where there is a higher prevalence of
HIV infection in pregnancy, testing policies are failing to
detect most HIV positive women before they give birth.11
There is therefore an urgent need to define the factors
that will increase uptake rates. The results of this study
show that requiring the midwives to offer the test and
documenting that offer results in a 35% uptake rate,
which is higher than in most units in London,5 where
practice is inconsistent and few have written protocols.11
Moreover, women found the test acceptable, no matter
how it was presented, and the most frequent reason
given for taking the test was “It’s a good idea to have as a
routine test.” In the light of this evidence, and in support
of the recent assertion that “the time has come to bring
HIV antibody testing alongside other diagnostic screen›
ing tests,”24 we propose assessing the acceptability of a
routine approach to testing, in which concise but specific
information and discussion is provided and the test is
done automatically unless the woman chooses not to be
tested.
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Endpiece
Hypothesis and fact
The great tragedy of Science–the slaying of a
beautiful hypothesis by an ugly fact.
Thomas Henry Huxley, Collected Essays (1893›4),
“Biogenesis and Abiogenesis”
Key messages
+ HIV testing in pregnancy is beneficial, but
uptake rates are not high
+ Offering the test to women attending antenatal
clinics increases uptake without increasing
anxiety or dissatisfaction
+ The extent of information given is not
important in terms of whether women take the
test and whether they find the procedure
acceptable
+ Uptake depends more on the midwife than the
method of offering the test
+ Low uptake rates and inadequate detection of
HIV infection point to the need to assess a
more routine approach to testing
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